Naylor ML, Yun J, Arnold D. No evidence of disease activity achievement over 4 years of peginterferon beta-1a treatment in newly diagnosed patients with relapsing Multiple Sclerosis: subgroup analyses of ADVANCE/ATTAIN. EAN 2018, poster EPR2116.
Verstoorde balans tussen hersennetwerken bij mensen met MS met cognitieve problemen
feb 2017 | Multipele Sclerose